A Risk Sciences International news item posted on November 4, 2025 and last updated on November 4, 2025

IARC recently published a volume on quantitative bias modelling: Bias assessment in case–control and cohort studies for hazard identification (IARC Scientific Publication No. 171). We are pleased to see inclusion of some of the work RSI’s Drs Franco Momoli and Daniel Krewski conducted for the INTERPHONE and MOBI-Kids studies of cell phones, radiofrequencies, and brain tumours as examples in the text. The IARC publication includes several fantastic resources that epidemiologists can add to their statistical armamentarium. This entails using data external to the study to address unmeasured confounders, measurement error on variables, and issues arising from selection into and out of study populations.

These methods, while still not widely adopted, are found in several modern epidemiologic textbooks, and they deserve wider appreciation. Recommendations have been made to use quantitative bias methods to more transparently discuss study limitations, to understand the robustness of study results during journal peer review, and to properly characterize sources of systematic bias in regulatory contexts. The first step is often planning for this work at the grant funding stage.

Work conducted by Risk Sciences International for Health Canada has also involved these approaches with benchmark dose modelling leading to deriving health-based regulatory values for drinking water and air quality. These methods typically use high quality key epidemiologic studies that, nevertheless, had limitations that deserve quantitative characterization of uncertainty.

Experts related to this news item

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

More RSI News

Quinolones and risk of retinal detachment

April 26, 2022

Following previous work on the potential risk of acute liver failure associated with quinolone antibiotics, RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel…

Read News Item

Value of information

April 22, 2022

Risk Sciences International (RSI) investigators Greg Paoli, Shintaro Hagiwara and Daniel Krewski collaborated with investigators from the US Center for Computational Toxicology and Exposure (CCTE)…

Read News Item

IAI climate change report

April 12, 2022

The International Aluminium Institute (IAI) recently commissioned Climate Risk Institute (CRI) and Risk Sciences International (RSI) to produce a series of informational tools evaluating and…

Read News Item

Quinolones and risk of acute liver failure

April 12, 2022

Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski,…

Read News Item